Pichatorn Suppakitjanusant
Overview
Explore the profile of Pichatorn Suppakitjanusant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suppakitjanusant P, Wang Y, Sivapiromrat A, Hu C, Binongo J, Hunt W, et al.
J Clin Transl Endocrinol
. 2024 Aug;
37:100362.
PMID: 39188269
Background: Cystic fibrosis (CF) is a multi-organ disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). Individuals with CF often have gastrointestinal (GI) dysbiosis due to chronic...
2.
Srifuengfung G, Suppakitjanusant P, Chaisrimaneepan N
Clin Case Rep
. 2024 Mar;
12(3):e8568.
PMID: 38444918
EBV infections rarely cause CNS involvement. For young adult patients with suspected CNS infection, bacterial and other common viral infections should be excluded first and treated empirically until proven otherwise....
3.
Sivapiromrat A, Suppakitjanusant P, Wang Y, Hu C, Binongo J, Hunt W, et al.
Contemp Clin Trials Commun
. 2024 Mar;
38:101278.
PMID: 38435430
Individuals with cystic fibrosis (CF) have dysfunctional intestinal microbiota and increased gastrointestinal (GI) inflammation also known as GI dysbiosis. It is hypothesized that administration of high-dose cholecalciferol (vitamin D) together...
4.
Sivapiromrat A, Suppakitjanusant P, Wang Y, Binongo J, Hunt W, Gewirtz A, et al.
medRxiv
. 2024 Feb;
PMID: 38343811
Individuals with cystic fibrosis (CF) have dysfunctional intestinal microbiota and increased gastrointestinal (GI) inflammation also known as GI dysbiosis. It is hypothesized that administration of high-dose cholecalciferol (vitamin D) together...
5.
Suppakitjanusant P, Kasemkosin N, Sivapiromrat A, Weinstein S, Ongphiphadhanakul B, Hunt W, et al.
Sci Rep
. 2023 Jul;
13(1):10707.
PMID: 37400506
No abstract available.
6.
Suppakitjanusant P, Kasemkosin N, Sivapiromrat A, Weinstein S, Ongphiphadhanakul B, Hunt W, et al.
Sci Rep
. 2023 May;
13(1):8617.
PMID: 37244957
Cystic fibrosis-related diabetes (CFRD) is associated with reduced life expectancy in adults with cystic fibrosis (CF). Voice analysis may be a convenient method for diagnosing and monitoring CFRD. This study...
7.
Charoenngam N, Rittiphairoj T, Ponvilawan B, Jaroenlapnopparat A, Waitayangkoon P, Suppakitjanusant P, et al.
Endocr Pract
. 2023 Feb;
29(7):589-600.
PMID: 36804968
Objective: To investigate bone fragility in patients with hereditary connective tissue disorders (HCTD), including Ehlers-Danlos syndrome (EDS), Marfan's syndrome (MFS) and Loeys-Dietz syndrome (LDS). Methods: From inception to June 2022,...
8.
Abdelnabi M, Rimu A, Suppakitjanusant P, Phy M
BMJ Case Rep
. 2023 Jan;
16(1.
PMID: 36653046
No abstract available.
9.
Jaroenlapnopparat A, Suppakitjanusant P, Ponvilawan B, Charoenngam N
Int J Mol Sci
. 2022 Aug;
23(16).
PMID: 36012386
Background: Studies have demonstrated the link between vitamin-D-related genetic variations and nonskeletal outcomes. We aimed to identify all available data on the association of vitamin-D-related genetic variations with nonalcoholic fatty...
10.
Gupta P, Suppakitjanusant P, Stevenson M, Goodman M, Tangpricha V
Endocr Pract
. 2022 Aug;
28(11):1113-1117.
PMID: 35964859
Objective: To assess the incidence of hyperkalemia in transgender women using spironolactone. Methods: This was a retrospective chart review of transgender women who received gender-affirming hormone therapy that included spironolactone...